Literature DB >> 15522956

A common founder mutation in FANCA underlies the world's highest prevalence of Fanconi anemia in Gypsy families from Spain.

Elsa Callén1, José A Casado, Marc D Tischkowitz, Juan A Bueren, Amadeu Creus, Ricard Marcos, Angeles Dasí, Jesús M Estella, Arturo Muñoz, Juan J Ortega, Johan de Winter, Hans Joenje, Detlev Schindler, Helmut Hanenberg, Shirley V Hodgson, Christopher G Mathew, Jordi Surrallés.   

Abstract

Fanconi anemia (FA) is a genetic disease characterized by bone marrow failure and cancer predisposition. Here we have identified Spanish Gypsies as the ethnic group with the world's highest prevalence of FA (carrier frequency of 1/64-1/70). DNA sequencing of the FANCA gene in 8 unrelated Spanish Gypsy FA families after retroviral subtyping revealed a homozygous FANCA mutation (295C>T) leading to FANCA truncation and FA pathway disruption. This mutation appeared specific for Spanish Gypsies as it is not found in other Gypsy patients with FA from Hungary, Germany, Slovakia, and Ireland. Haplotype analysis showed that Spanish Gypsy patients all share the same haplotype. Our data thus suggest that the high incidence of FA among Spanish Gypsies is due to an ancestral founder mutation in FANCA that originated in Spain less than 600 years ago. The high carrier frequency makes the Spanish Gypsies a population model to study FA heterozygote mutations in cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15522956     DOI: 10.1182/blood-2004-07-2588

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Origin, functional role, and clinical impact of Fanconi anemia FANCA mutations.

Authors:  Maria Castella; Roser Pujol; Elsa Callén; Juan P Trujillo; José A Casado; Hans Gille; Francis P Lach; Arleen D Auerbach; Detlev Schindler; Javier Benítez; Beatriz Porto; Teresa Ferro; Arturo Muñoz; Julián Sevilla; Luis Madero; Elena Cela; Cristina Beléndez; Cristina Díaz de Heredia; Teresa Olivé; José Sánchez de Toledo; Isabel Badell; Montserrat Torrent; Jesús Estella; Angeles Dasí; Antonia Rodríguez-Villa; Pedro Gómez; José Barbot; María Tapia; Antonio Molinés; Angela Figuera; Juan A Bueren; Jordi Surrallés
Journal:  Blood       Date:  2011-01-27       Impact factor: 22.113

2.  How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel.

Authors:  Philip S Rosenberg; Hannah Tamary; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2011-07-07       Impact factor: 2.802

3.  Comprehensive analysis of pathogenic deletion variants in Fanconi anemia genes.

Authors:  Elizabeth K Flynn; Aparna Kamat; Francis P Lach; Frank X Donovan; Danielle C Kimble; Narisu Narisu; Erica Sanborn; Farid Boulad; Stella M Davies; Alfred P Gillio; Richard E Harris; Margaret L MacMillan; John E Wagner; Agata Smogorzewska; Arleen D Auerbach; Elaine A Ostrander; Settara C Chandrasekharappa
Journal:  Hum Mutat       Date:  2014-11       Impact factor: 4.878

Review 4.  Genetic counseling for Fanconi anemia: crosslinking disciplines.

Authors:  Heather A Zierhut; Rebecca Tryon; Erica M Sanborn
Journal:  J Genet Couns       Date:  2014-09-20       Impact factor: 2.537

5.  Tau haplotypes support the Asian ancestry of the Roma population settled in the Basque Country.

Authors:  Miguel A Alfonso-Sánchez; Ibone Espinosa; Luis Gómez-Pérez; Alaitz Poveda; Esther Rebato; Jose A Peña
Journal:  Heredity (Edinb)       Date:  2017-12-11       Impact factor: 3.821

6.  A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families.

Authors:  Danielle C Kimble; Francis P Lach; Siobhan Q Gregg; Frank X Donovan; Elizabeth K Flynn; Aparna Kamat; Alice Young; Meghana Vemulapalli; James W Thomas; James C Mullikin; Arleen D Auerbach; Agata Smogorzewska; Settara C Chandrasekharappa
Journal:  Hum Mutat       Date:  2017-11-22       Impact factor: 4.878

7.  Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Authors:  Reinhard Kalb; Kornelia Neveling; Holger Hoehn; Hildegard Schneider; Yvonne Linka; Sat Dev Batish; Curtis Hunt; Marianne Berwick; Elsa Callen; Jordi Surralles; Jose A Casado; Juan Bueren; Angeles Dasi; Jean Soulier; Eliane Gluckman; C Michel Zwaan; Rosalina van Spaendonk; Gerard Pals; Johan P de Winter; Hans Joenje; Markus Grompe; Arleen D Auerbach; Helmut Hanenberg; Detlev Schindler
Journal:  Am J Hum Genet       Date:  2007-04-06       Impact factor: 11.025

8.  Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.

Authors:  Massimo Bogliolo; Alex Lyakhovich; Elsa Callén; Maria Castellà; Enrico Cappelli; María J Ramírez; Amadeu Creus; Ricard Marcos; Reinhard Kalb; Kornelia Neveling; Detlev Schindler; Jordi Surrallés
Journal:  EMBO J       Date:  2007-02-15       Impact factor: 11.598

9.  Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs.

Authors:  Guang-Hui Liu; Keiichiro Suzuki; Mo Li; Jing Qu; Nuria Montserrat; Carolina Tarantino; Ying Gu; Fei Yi; Xiuling Xu; Weiqi Zhang; Sergio Ruiz; Nongluk Plongthongkum; Kun Zhang; Shigeo Masuda; Emmanuel Nivet; Yuji Tsunekawa; Rupa Devi Soligalla; April Goebl; Emi Aizawa; Na Young Kim; Jessica Kim; Ilir Dubova; Ying Li; Ruotong Ren; Chris Benner; Antonio Del Sol; Juan Bueren; Juan Pablo Trujillo; Jordi Surralles; Enrico Cappelli; Carlo Dufour; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Nat Commun       Date:  2014-07-07       Impact factor: 14.919

Review 10.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.